Is combination antiviral therapy for influenza the optimal approach? | Lancet Infect Dis;22(5): 587-588, 2022 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Is combination antiviral therapy for influenza the optimal approach?

Lampejo, Temi.

Lampejo T; Department of Infection Sciences, King's College Hospital, London, UK. Electronic address: temi.lampejo@nhs.net.

Lancet Infect Dis ; 22(5): 587-588, 2022 05.

Article in English | MEDLINE | ID: covidwho-1805391

Subject(s)

Influenza, Human; Antiviral Agents/therapeutic use; Combined Modality Therapy; Drug Therapy, Combination; Humans; Influenza, Human/drug therapy; Oseltamivir/therapeutic use

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article